pembrolizumab,pds0101
pds biotech,merck
['pds0101', 'headandneck', 'keytruda', 'pdsbio', 'pds bio']
dr. katharine price from the mayo clinic speaking about the interim data from the versatile-002 study (pds0101/keytruda) for advanced hpv16 #headandneckcancer at #asco23. the data showed extended survival and a benign safety profile vs previously published studies. #oncology 
PDS Biotech is a clinical-stage biotech company developing cancer therapies and infectious disease vaccines based on Versamune®, a T-cell activating technology.